Allopurinol in the prevention of superficial bladder tumour recurrence

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2005
INTERVENTION: Trade Name: Allopurinol Pharmaceutical Form: Pharmaceutical Form: CONDITION: Superficial Bladder Cancer ‐ Role of allopurinol in prevention of tumour recurrence PRIMARY OUTCOME: Main Objective: Primary end point(s): Secondary Objective: INCLUSION CRITERIA: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18‐64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Epistemonikos ID: 123be4f731dcc2afa23b3857278ce15440170c2c
First added on: Aug 21, 2024